EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Therapeutic potential of gut microbiota modulation in epilepsy: A focus on short-chain fatty acids

Rong Yan, Linhai Zhang, Ya Chen, Yongsu Zheng, Ping Xu, Zucai Xu

Neurobiology of Disease · 2025

DOI: 10.1016/j.nbd.2025.106880 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Neurobiology of Disease, 2025. Verfasst von Rong Yan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Affiliated Hospital of Zunyi Medical University, Zunyi, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Fatty Acids, Volatile, Epilepsy. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 140 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Ministry of Education of the People's Republic of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

According to the criteria established by the International League Against Epilepsy (ILAE), epilepsy is defined as a disorder characterized by at least two unprovoked seizures occurring more than 24 h apart. Its pathogenesis is closely related to various physiological and pathological factors. Advances in high-throughput metagenomic sequencing have increasingly highlighted the role of gut microbiota dysbiosis in epilepsy. Short-chain fatty acids (SCFAs), the major metabolites of the gut microbiota and key regulators of the gut-brain axis, support physiological homeostasis through multiple mechanisms. Recent studies have indicated that SCFAs not only regulate seizures by maintaining intestinal barrier integrity and modulating intestinal immune responses, but also affect the structure and function of the blood-brain barrier (BBB) and regulate neuroinflammation. This review, based on current literatures, explores the relationship between SCFAs and epilepsy, emphasizing how SCFAs affect epilepsy by modulating the intestinal barrier and BBB. In-depth studies on SCFAs may reveal their therapeutic potential and inform the development of gut microbiota-targeted epilepsy treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeFatty Acids, VolatileEpilepsyHumansBlood-Brain BarrierAnimalsDysbiosis

Stichwörter der Autor:innen

Blood-brain barrierEpilepsyGut microbiotaIntestinal barrierSCFAs

Substanzen

Fatty Acids, Volatile

Autor:innen und Institutionen

  • Department of Neurology, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
  • Department of Neurology, Affiliated Hospital of Zunyi Medical University, Zunyi, China. Electronic address: xuping@zmu.edu.cn.
  • Department of Neurology, Affiliated Hospital of Zunyi Medical University, Zunyi, China; Key Laboratory of Brain Function and Brain Disease Prevention and Treatment of Guizhou Province, Zunyi, China. Electronic address:…

Förderung

  • National Natural Science Foundation of China
  • Ministry of Education of the People's Republic of China

Zitieren

APA

Yan, R., Zhang, L., Chen, Y., Zheng, Y., Xu, P., & Xu, Z. (2025). Therapeutic potential of gut microbiota modulation in epilepsy: A focus on short-chain fatty acids. Neurobiology of Disease. https://doi.org/10.1016/j.nbd.2025.106880

Vancouver

Yan R, Zhang L, Chen Y, Zheng Y, Xu P, Xu Z. Therapeutic potential of gut microbiota modulation in epilepsy: A focus on short-chain fatty acids. Neurobiology of Disease. 2025. doi:10.1016/j.nbd.2025.106880

BibTeX
@article{Yan2025,
  author = {Yan, Rong and Zhang, Linhai and Chen, Ya and Zheng, Yongsu and Xu, Ping and Xu, Zucai},
  title = {Therapeutic potential of gut microbiota modulation in epilepsy: A focus on short-chain fatty acids},
  journal = {Neurobiology of Disease},
  year = {2025},
  doi = {10.1016/j.nbd.2025.106880}
}
Kostenlos starten →